What to expect from targeted therapy for gastrointestinal stromal tumour

Gastrointestinal stromal tumours, also called GIST, may contain changes that activate growth signals. A targeted medicine can block a relevant signal rather than affecting every rapidly dividing cell. Testing of tumour tissue helps the team understand which treatment is likely to fit your tumour.

Many targeted medicines for GIST are taken as tablets on a repeating schedule. Your clinician may review scans, symptoms and blood tests to assess whether the tumour is stable, shrinking or changing. Treatment decisions also consider whether surgery is planned and whether the disease has returned or spread.

Take each dose as directed and ask whether it should be taken with food. Keep a list of prescription medicines, herbal products and vitamins, because interactions can change drug levels. Report swelling, rash, diarrhoea, nausea, fatigue, muscle cramps or changes in appetite rather than silently missing doses.

Attend blood tests and imaging appointments. These checks can identify effects on blood counts, liver function or other organs before you notice a problem. Store tablets safely and ask what to do if you vomit after taking one.

Seek prompt medical advice for fever, persistent vomiting or diarrhoea, yellowing of the skin, dark urine, severe abdominal pain, unusual bleeding, sudden swelling or a rapidly spreading rash. Emergency care is needed for severe breathing difficulty, fainting, chest pain or signs of a serious allergic reaction.

What tumour test guides my treatment? How should I take the tablet? Which side effects can be managed at home? When are scans and blood tests due? What happens if the tumour stops responding?